Methods to reduce prescribing errors in elderly patients with multimorbidity

Clinical Interventions in Aging

Volumn 11, Issue , 2016, Pages 857-866

  Lavan, Amanda H ^a   Gallagher, Paul F ^a   O’Mahony, Denis ^a  

^a Department of Medicine National University of Ireland Cork   (Ireland)

Author keywords

Aged; Multimorbidity; Prescribing errors

Indexed keywords

AGE; COST BENEFIT ANALYSIS; ELDERLY CARE; ENVIRONMENTAL FACTOR; HEALTH EDUCATION; HOSPITAL READMISSION; HUMAN; INAPPROPRIATE PRESCRIBING; INFORMATION TECHNOLOGY; MEDICATION ERROR; MEDICATION THERAPY MANAGEMENT; PHARMACIST; POPULATION RESEARCH; PREVALENCE; REVIEW; RISK ASSESSMENT; WORK ENVIRONMENT; AGED; COMORBIDITY; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; EDUCATION; GERIATRICS; PHYSICIAN; POLYPHARMACY; POTENTIALLY INAPPROPRIATE MEDICATION; PREVENTION AND CONTROL; PROCEDURES; RISK FACTOR;

AGED; COMORBIDITY; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; EDUCATION, PHARMACY; GERIATRICS; HUMANS; INAPPROPRIATE PRESCRIBING; MEDICATION RECONCILIATION; PHARMACISTS; PHYSICIANS; POLYPHARMACY; POTENTIALLY INAPPROPRIATE MEDICATION LIST; RISK FACTORS;

EID: 84978958306     PISSN: 11769092     EISSN: 11781998     Source Type: Journal    
DOI: 10.2147/CIA.S80280     Document Type: Review

References (69)

1. United Nations. World Population Ageing 2013. New York: UN; 2013.
2. Centers for Disease Control and Prevention (CDC). Trends in aging - United States and worldwide. MMWR Morb Mortal Wkly Rep. 2003; 52(6):101-104, 106.
3. Salive ME. Multimorbidity in older adults. Epidemiol Rev. 2013; 35(1):75-83.
4. Jacobs JM, Maaravi Y, Cohen A, Bursztyn M, Ein-Mor E, Stessman J. Changing profile of health and function from age 70 to 85 years. Gerontology. 2012;58(4):313-321.
5. Steinman MA, Landefeld CS, Rosenthal GE, Berthenthal D, Sen S, Kaboli PJ. Polypharmacy and prescribing quality in older people. J Am Geriatr Soc. 2006;54(10):1516-1523.
6. Goldberg RM, Mabee J, Chan L, Wong S. Drug-drug and drug-disease interactions in the ED: analysis of a high-risk population. Am J Emerg Med. 1996;14(5):447-450.
7. Maher RL, Hanlon J, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf. 2014;13(1):57-65.
8. Stawicki SP, Gerlach AT. Polypharmacy and medication errors: stop, listen, look, and analyze. Opus 12 Sci. 2009;3(1):6-10.
9. Ferner RE, Aronson JK. Clarification of terminology in medication errors: definitions and classification. Drug Saf. 2006;29(11): 1011-1022.
10. Dean B, Barber N, Schachter M. What is a prescribing error? Qual Health Care. 2000;9(4):232-237.
11. Tam VC, Knowles SR, Cornish PL, Fine N, Marchesano R, Etchells EE. Frequency, type and clinical importance of medication history errors at admission to hospital: a systematic review. CMAJ. 2005; 173(5):510-515.
12. Lewis PJ, Dornan T, Taylor D, Tully MP, Wass V, Ashcroft DM. Prevalence, incidence and nature of prescribing errors in hospital inpatients. Drug Saf. 2009;32(5):379-389.
13. Ashcroft DM, Lewis PJ, Tully MP, et al. Prevalence, nature, severity and risk factors for prescribing errors in hospital inpatients: prospective study in 20 UK hospitals. Drug Saf. 2015;38(9):833-843.
14. Avery T, Barber N, Ghaleb M, et al. Investigating the prevalence and causes of prescribing errors in general practice. 2012. Available from: http://www.gmc-uk.org/about/research/25043.asp. Accessed December 15, 2015.
15. Moore KL, Boscardin WJ, Steinman MA, Schwartz JB. Patterns of chronic co-morbid medical conditions in older residents of U.S. nursing homes: differences between the sexes and across the agespan. J Nutr Health Aging. 2014;18(4):429-436.
16. Barber N, Alldred D, Raynor D, et al. Care homes’ use of medicines study: prevalence, causes and potential harm of medication errors in care homes for older people. Qual Saf Health Care. 2009;18(5):341-346.
17. Midlöv P, Bergkvist A, Bondesson A, Eriksson T, Höglund P. Medication errors when transferring elderly patients between primary health care and hospital care. Pharm World Sci. 2005;27(2):116-120.
18. CARDI Centre for Ageing Research and Development in Ireland [homepage on the Internet]. Available from: http://www.cardi.ie/publications?keys=&&&&page=80. Accessed January 18, 2012.
19. Harris-Kojetin L, Sengupta M, Park-Lee E, Valverde R. Long-Term Care Services in the United States: 2013 Overview. Vital Health Stat 3. 2013;(37):1-107.
20. Hetzel L, Smith A. The 65 years and over population: 2000. 2001. Available from: https://www.census.gov/prod/2001pubs/c2kbr01-10.pdf. Accessed December 15, 2015.
21. Fijn R, Van den Bemt PM, Chow M, De Blaey CJ, DeJong-Vanden Berg LT, Brouwers JR. Hospital prescribing errors: epidemiological assessment of predictors. Br J Clin Pharmacol. 2002;53(3):326-331.
22. Dean B, Schachter M, Vincent C, Barber N. Causes of prescribing errors in hospital inpatients: a prospective study. Lancet. 2002;359(9315): 1373-1378.
23. Frank C, Godwin M, Verma S, et al. What drugs are our frail elderly patients taking? Do drugs they take or fail to take put them at increased risk of interactions and inappropriate medication use? Can Fam Physician. 2001;47(6):1198-1204.
24. Dornan T, Ashcroft D, Heathfield H, et al. An in-depth investigation into causes of prescribing errors by foundation trainees in relation to their medical education - EQUIP study. 2009. Available from: http://www.gmc-uk.org/FINAL_Report_prevalence:and_causes_of_prescribing_errors.pdf_28935150.pdf. Accessed December 15, 2015.
25. Woodhouse KW, Wynne HA. Age-related changes in liver size and hepatic blood flow: the influence on drug metabolism in the elderly. Clin Pharmacokinet. 1988;15(5):287-294.
26. Mangoni AA, Jackson SH. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol. 2004;57(1):6-14.
27. Khan LM. Comparative epidemiology of hospital-acquired adverse drug reactions in adults and children and their impact on cost and hospital stay - a systematic review. Eur J Clin Pharmacol. 2013;69(12): 1985-1996.
28. Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients. BMJ. 2004;329(7456):15-19.
29. Corsonello A, Pedone C, Corica F, Mussi C, Carbonin P, Antonelli Incalzi R. Concealed renal insufficiency and adverse drug reactions in elderly hospitalized patients. Arch Intern Med. 2005;165(7): 790-795.
30. Bates DW, Boyle DL, Vander Vliet MB, Schneider J, Leape L. Relationship between medication errors and adverse drug events. J Gen Intern Med. 1995;10(4):199-205.
31. Dean B, Schachter M, Vincent C, Barber N. Prescribing errors in hospital inpatients: their incidence and clinical significance. Qual Saf Health Care. 2002;11(4):340-344.
32. Heaton A, Webb DJ, Maxwell SR. Undergraduate preparation for prescribing: the views of 2413 UK medical students and recent graduates. Br J Clin Pharmacol. 2008;66(1):128-134.
33. Illing J, Morrow G, Kergon C, et al. How prepared are medical graduates to begin practice? A comparison of three diverse UK medical schools. 2008. Available from: http://www.gmc-uk.org/FINAL_How_prepared_are_medical_graduates_to_begin_practice:September_08.pdf_29697834.pdf. Accessed December 15, 2015.
34. Ryan C, Ross S, Davey P, et al. Prevalence and causes of prescribing errors: the PRescribing Outcomes for Trainee doctors Engaged in Clinical Training (PROTECT) study. PloS One. 2014;9(1):e79802.
35. Ross S, Loke YK. Do educational interventions improve prescribing by medical students and junior doctors? A systematic review. Br J Clin Pharmacol. 2009;67(6):662-670.
36. Guide to Good Prescribing: a practical manual (WHO/DAP/94.11). TPG De Vries, RH Henning, HV Hogerzeil, DA Fresle. WHO Action Programme on Essential Drugs. WHO, Geneva, 1994. Available from: http://apps.who.int/medicinedocs/pdf/whozip23e/whozip23e.pdf. Accessed January 21, 2016.
37. Gallagher P, Ryan C, Byrne S, Kennedy J, O’Mahony D. STOPP (screening tool of older person’s prescriptions) and START (screening tool to alert doctors to right treatment): consensus validation. Int J Clin Pharmacol Ther. 2008;46(2):72-83.
38. Keijsers CJ, van Doorn AB, van Kalles A, et al. Structured pharmaceutical analysis of the systematic tool to reduce inappropriate prescribing is an effective method for final-year medical students to improve polypharmacy skills: a randomized controlled trial. J Am Geriatr Soc. 2014;62(7):1353-1359.
39. Bloom BS. Effects of continuing medical education on improving physician clinical care and patient health: a review of systematic reviews. Int J Technol Assess Health Care. 2005;21(3): 380-385.
40. Cullinan S, O’Mahony D, Fleming A, Byrne S. A meta-synthesis of potentially inappropriate prescribing in older patients. Drugs Aging. 2014;31(8):631-638.
41. Cullinan S, Fleming A, O’Mahony D, et al. Doctors’ perspectives on the barriers to appropriate prescribing in older hospitalized patients: a qualitative study. Br J Clin Pharmacol. 2015;79(5):860-869.
42. Cullinan S. Use of an e-learning educational module to better equip doctors to prescribe for older patients: a randomised controlled trial. (pp 82-98). In: Strategies to prevent potentially inappropriate prescribing and adverse drug reactions in older patients. [PhD thesis] National University of Ireland, University College Cork, 2015.
43. Masud T, Blundell A, Gordon AL, et al. European undergraduate curriculum in geriatric medicine developed using an international modified Delphi technique. Age Ageing. 2014;43(5):695-702.
44. Drenth-van Maanen AC, Spee J, van Hensbergen L, Jansen PA, Egberts TC, van Marum RJ. Structured history taking of medication use reveals iatrogenic harm due to discrepancies in medication histories in hospital and pharmacy records. J Am Geriatr Soc. 2011;59(10):1976-1977.
45. Dale MA, Copeland R, Barton R. Prescribing errors on medical wards and the impact of clinical pharmacists. Int J Pharm Pract. 2003;11(1): 19-24.
46. Tully MP, Buchan IE. Prescribing errors during hospital inpatient care: factors influencing identification by pharmacists. Pharm World Sci. 2009;31(6):682-688.
47. Abdel-Qader DH, Harper L, Cantrill JA, Tully MP. Pharmacists’ interventions in prescribing errors at hospital discharge. Drug Saf. 2010;33(11):1027-1044.
48. Klopotowska JE, Kuiper R, van Kan HJ, et al. On-ward participation of a hospital pharmacist in a Dutch intensive care unit reduces prescribing errors and related patient harm: an intervention study. Crit Care. 2010; 14(5):R174.
49. Bagshaw SM, Webb SA, Delaney A, et al. Very old patients admitted to intensive care in Australia and New Zealand: a multi-centre cohort analysis. Crit Care. 2009;13(2):R45.
50. Coombes I, Stowasser D, Reid C, Mitchell C. Impact of a standard medication chart on prescribing errors: a before-and-after audit. Qual Saf Health Care. 2009;18(6):478-485.
51. Reckmann MH, Westbrook JI, Koh Y, Lo C, Day RO. Does computerized provider order entry reduce prescribing errors for hospital inpatients? A systematic review. J Am Med Inform Assoc. 2009;16(5):613-623.
52. Abramson EL, Barrón Y, Quaresimo J, Kaushal R. Electronic prescribing within an electronic health record reduces ambulatory prescribing errors. Jt Comm J Qual Patient Saf. 2011;37(10):470-478.
53. Kaushal R, Kern LM, Barrón Y, Quaresimo J, Abramson EL. Electronic prescribing improves medication safety in community-based office practices. J Gen Intern Med. 2010;25(6):530-536.
54. Donyai P, O’Grady K, Jacklin A, Barber N, Franklin BD. The effects of electronic prescribing on the quality of prescribing. Br J Clin Pharmacol. 2008;65(2):230-237.
55. Hanlon JT, Schmader KE, Samsa GP, et al. A method for assessing drug therapy appropriateness. J Clin Epidemiol. 1992;45(10):1045-1051.
56. Samsa GP, Hanlon JT, Schmader KE, et al. A summated score for the Medication Appropriateness Index: development and assessment of clinimetric properties including content validity. J Clin Epidemiol. 1994;47(8):891-896.
57. Hanlon JT, Schmader KE. The Medication Appropriateness Index at 20: where it started, where it has been, and where it may be going. Drugs Aging. 2013;30(11):893-900.
58. Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck JC. Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med. 1991;151(9):1825-1832.
59. American Geriatrics Society 2015 Beers Criteria Update Expert Panel. American Geriatrics Society 2015 updated Beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2015;63(11):2227-2246.
60. O’Connor MN, Gallagher P, O’Mahony D. Inappropriate prescribing: criteria, detection and prevention. Drugs Aging. 2012;29(6):437-452.
61. O’Mahony D, O’Sullivan D, Byrne S, O’Connor MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44(2):213-218.
62. O’Mahony D, Gallagher PF. Inappropriate prescribing in the older population: need for new criteria. Age Ageing. 2008;37(2):138-141.
63. Gallagher PF, O’Connor MN, O’Mahony D. Prevention of potentially inappropriate prescribing for elderly patients: a randomized controlled trial using STOPP/START criteria. Clin Pharmacol Ther. 2011;89(6):845-854.
64. Frankenthal D, Lerman Y, Kalendaryev E, Lerman Y. Intervention with the screening tool of older persons potentially inappropriate prescriptions/screening tool to alert doctors to right treatment criteria in elderly residents of a chronic geriatric facility: a randomized clinical trial. J Am Geriatr Soc. 2014;62(9):1658-1665.
65. Dalleur O, Boland B, Losseau C, et al. Reduction of potentially inappropriate medications using the STOPP criteria in frail older inpatients: a randomised controlled study. Drugs Aging. 2014;31(4):291-298.
66. Schmader KE, Hanlon JT, Pieper CF, et al. Effects of geriatric evaluation and management on adverse drug reactions and suboptimal prescribing in the frail elderly. Am J Med. 2004;116(6):394-401.
67. Gillespie U, Alassaad A, Henrohn D, et al. A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older: a randomized controlled trial. Arch Intern Med. 2009;169(9):894-900.
68. Trivalle C, Cartier T, Verny C, et al. Identifying and preventing adverse drug events in elderly hospitalised patients: a randomised trial of a program to reduce adverse drug effects. J Nutr Health Aging. 2010; 14(1):57-61.
69. Hellström LM, Bondesson A, Höglund P, et al. Impact of the Lund Integrated Medicines Management (LIMM) model on medication appropriateness and drug-related hospital revisits. Eur J Clin Pharmacol. 2011;67(7):741-752.